Correlation Between Praxis Precision and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Candel Therapeutics, you can compare the effects of market volatilities on Praxis Precision and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Candel Therapeutics.
Diversification Opportunities for Praxis Precision and Candel Therapeutics
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Praxis and Candel is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Praxis Precision i.e., Praxis Precision and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Praxis Precision and Candel Therapeutics
Given the investment horizon of 90 days Praxis Precision Medicines is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Praxis Precision Medicines is 3.75 times less risky than Candel Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 447.00 in Candel Therapeutics on September 13, 2024 and sell it today you would earn a total of 328.00 from holding Candel Therapeutics or generate 73.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Praxis Precision Medicines vs. Candel Therapeutics
Performance |
| Timeline |
| Praxis Precision Med |
| Candel Therapeutics |
Praxis Precision and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Praxis Precision and Candel Therapeutics
The main advantage of trading using opposite Praxis Precision and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Praxis Precision vs. Molecular Partners AG | Praxis Precision vs. Mineralys Therapeutics, Common | Praxis Precision vs. AN2 Therapeutics | Praxis Precision vs. Pharvaris BV |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |